M11.83
Other specified crystal arthropathies, wrist
Clinical Classification Guidelines
Medical Intelligence & Overview
Other specified crystal arthropathies of the wrist, classified under ICD-10 code M11.83, are a group of joint conditions caused by the accumulation of crystal deposits in the wrist joint. These crystals lead to inflammation, pain, and swelling, often mimicking other forms of arthritis. Unlike more common types such as gout or pseudogout, this category encompasses less typical or more precisely defined crystal-related conditions affecting the wrist.
Causes & Symptoms
Clinical Causes: Accumulation of monosodium urate crystals, often associated with gout. Presence of calcium pyrophosphate dihydrate (CPPD) crystals, linked to pseudogout. Metabolic disorders that alter crystal formation, including hyperuricemia or calcium metabolism abnormalities. Repeated joint trauma or injury that predisposes crystals to form within the joint. Age-related changes, as crystal deposits tend to increase with advancing age. Genetic predispositions affecting crystal metabolism or joint health. Certain medications or lifestyle factors influencing crystal solubility or joint health.
Key Symptoms: Sudden or gradual joint pain in the wrist. Swelling and redness around the affected joint. Stiffness and limited range of motion in the wrist. Warmth over the joint area. Possible formation of tophi or visible nodules around the wrist in chronic cases. Intermittent episodes of exacerbation and remission of symptoms.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. A healthcare provider may perform a physical exam to assess swelling, warmth, and mobility. Joint fluid analysis under microscopy can identify the presence of specific crystals, confirming the type of crystal arthropathy. Imaging studies such as X-rays can reveal joint damage or crystal deposits, although they are not definitive. Blood tests for uric acid levels or calcium levels might support the diagnosis but are not solely diagnostic.
Treatment Protocols: Management of other specified crystal arthropathies typically includes medications to relieve inflammation and manage symptoms. These may involve nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids, depending on severity and individual patient factors. Lifestyle modifications, such as dietary changes to reduce crystal-forming substances, weight management, and hydration, are also recommended. In some cases, long-term therapies to lower uric acid or calcium levels may be necessary to prevent recurrent episodes. Physical therapy might help improve joint function, and surgical options are considered in severe or chronic cases where joint damage is significant.
Clinical Advice & FAQs
Billing Guidance
Is M11.83 a billable ICD-10 code?
Yes, M11.83 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.83?
Clinical documentation must specify the nature of Other specified crystal arthropathies, wrist and any associated comorbidities for accurate reporting.
Cite this Clinical Reference